scispace - formally typeset
S

Silvia Volpe

Researcher at University of Palermo

Publications -  9
Citations -  1148

Silvia Volpe is an academic researcher from University of Palermo. The author has contributed to research in topics: Cancer stem cell & Receptor. The author has an hindex of 9, co-authored 9 publications receiving 979 citations. Previous affiliations of Silvia Volpe include University of Würzburg.

Papers
More filters
Journal ArticleDOI

CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis

TL;DR: It is shown that all colorectal cancer stem cells (CR-CSCs) express CD44v6, which is required for their migration and generation of metastatic tumors, and phosphatidylinositol 3-kinase (PI3K) inhibition selectively killed CD 44v6 CR-C SCs and reduced metastatic growth.
Journal ArticleDOI

Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment

TL;DR: It is suggested that inhibition of glycolysis may be a potentially effective strategy to target BCSCs, and functional validation of proteomic and metabolic data provide evidences for increased activities of key enzymes of anaerobic glucose fate in cancer stem cells as well as different redox status.
Journal ArticleDOI

CCR2 acts as scavenger for CCL2 during monocyte chemotaxis.

TL;DR: Observations indicate that during chemotaxis CCR2 acts as scavenger consuming the chemokine forming the attracting cue, and cycles rapidly back to the plasma membrane to maintain high responsiveness after relocation of the source of attractant.
Journal ArticleDOI

Persistent cAMP Signaling by Internalized LH Receptors in Ovarian Follicles

TL;DR: This study indicates that the recently proposed paradigm of cAMP signaling by internalized G protein-coupled receptors is implicated in receptor function and is physiologically relevant.
Journal ArticleDOI

miR-205-5p -mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance

TL;DR: It is reported that miR-205-5p is highly expressed in BCSCs and represses directly ERBB2 and indirectly EGFR leading to resistance to targeted therapy and it is shown that p63 directly regulates the expression of p63 which is in turn involved in the EGFR expression suggesting a miR/p63/EGFR regulation.